Section 27-13-42-1 - Allowing a health maintenance organization to report the number of children enrollees who are prescribed stimulant medication for the treatment of certain disordersA health maintenance organization that enters into an individual contract or a group contract that provides a prescription drug benefit may report to the drug utilization review board established by IC 12-15-35-19, not later than October 1 of each calendar year, the number of enrollees who are:
(1) less than eighteen (18) years of age; and(2) prescribed a stimulant medication approved by the federal Food and Drug Administration for the treatment of attention deficit disorder or attention deficit hyperactivity disorder.As added by P.L. 107-2002, SEC.30.